Skip to main content
SpringerLink
Log in

Obesity and Kidney Cancer

  • Chapter
  • First Online:
Obesity and Cancer

Part of the book series: Recent Results in Cancer Research ((RECENTCANCER,volume 208))

Abstract

Renal cell cancer (RCC) is the major type of kidney cancer with increasing incidence. Obesity is one of the well-established risk factors for RCC. Meta-analyses including multiple cohort and case–control studies have found a consistent positive association between obesity and RCC. The association appeared to be independent of other RCC risk factors including hypertension and has been often stronger in women, although a positive association has also been observed in men. Obesity has been largely measured as body mass index (BMI). Studies which evaluated other measures of obesity including waist circumference (WC), waist-to-hip ratio (WHR) as well as increase in weight have reported similar positive associations with RCC. Although the mechanisms by which obesity influences renal carcinogenesis have been under-explored, insulin resistance and certain growth factors including insulin-like growth factor (IGF-1), sex steroid hormones, and biochemical markers such as adiponectin may be involved. The positive association with obesity has been observed with the clear cell type of RCC, which is the major histological subtype. On the other hand, the association between obesity and RCC survival appears to be much more complex. An apparent inverse association between obesity at time of diagnosis and RCC survival has been observed in some studies‚ generating speculation of an “obesity paradox” hypothesis. However, this “paradox” may be due to reverse causation, selection bias, or other forms of bias rather than a true biological association.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 99.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 129.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 179.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D, Bray F (2015) Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 136(5):E359–E386. doi:10.1002/ijc.29210

    Article  CAS  PubMed  Google Scholar 

  2. Muglia VF, Prando A (2015) Renal cell carcinoma: histological classification and correlation with imaging findings. Radiol Bras 48(3):166–174. doi:10.1590/0100-3984.2013.1927

    Article  PubMed  PubMed Central  Google Scholar 

  3. Chow WH, Devesa SS (2008) Contemporary epidemiology of renal cell cancer. Cancer J 14(5):288–301. doi:10.1097/PPO.0b013e3181867628

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Hock LM, Lynch J, Balaji KC (2002) Increasing incidence of all stages of kidney cancer in the last 2 decades in the United States: an analysis of surveillance, epidemiology and end results program data. J Urol 167(1):57–60

    Article  PubMed  Google Scholar 

  5. Capitanio U, Montorsi F (2015) Renal cancer. Lancet. doi:10.1016/S0140-6736(15)00046-X

    PubMed  Google Scholar 

  6. Cho E, Adami HO, Lindblad P (2011) Epidemiology of renal cell cancer. Hematol Oncol Clin North Am 25(4):651–665. doi:10.1016/j.hoc.2011.04.002

    Article  PubMed  Google Scholar 

  7. Lucca I, Klatte T, Fajkovic H, de Martino M, Shariat SF (2015) Gender differences in incidence and outcomes of urothelial and kidney cancer. Nat Rev Urol 12(10):585–592. doi:10.1038/nrurol.2015.232

    Article  CAS  PubMed  Google Scholar 

  8. Bergstrom A, Hsieh CC, Lindblad P, Lu CM, Cook NR, Wolk A (2001) Obesity and renal cell cancer—a quantitative review. Br J Cancer 85(7):984–990

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Calle EE, Kaaks R (2004) Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms. Nat Rev 4(8):579–591. doi:10.1038/nrc1408

    Article  CAS  Google Scholar 

  10. Carnethon MR, De Chavez PJ, Biggs ML, Lewis CE, Pankow JS, Bertoni AG, Golden SH, Liu K, Mukamal KJ, Campbell-Jenkins B, Dyer AR (2012) Association of weight status with mortality in adults with incident diabetes. JAMA 308(6):581–590. doi:10.1001/jama.2012.9282

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Padwal R, McAlister FA, McMurray JJ, Cowie MR, Rich M, Pocock S, Swedberg K, Maggioni A, Gamble G, Ariti C, Earle N, Whalley G, Poppe KK, Doughty RN, Bayes-Genis A, Meta-analysis Global Group in Chronic Heart F (2014) The obesity paradox in heart failure patients with preserved versus reduced ejection fraction: a meta-analysis of individual patient data. Int J Obes (Lond) 38(8):1110–1114. doi:10.1038/ijo.2013.203

    Google Scholar 

  12. Wang F, Xu Y (2014) Body mass index and risk of renal cell cancer: a dose-response meta-analysis of published cohort studies. Int J Cancer 135(7):1673–1686. doi:10.1002/ijc.28813

    Article  CAS  PubMed  Google Scholar 

  13. Rapp K, Schroeder J, Klenk J, Stoehr S, Ulmer H, Concin H, Diem G, Oberaigner W, Weiland SK (2005) Obesity and incidence of cancer: a large cohort study of over 145,000 adults in Austria. Br J Cancer 93(9):1062–1067. doi:10.1038/sj.bjc.6602819

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Samanic C, Chow WH, Gridley G, Jarvholm B, Fraumeni JF Jr (2006) Relation of body mass index to cancer risk in 362,552 Swedish men. Cancer Causes Control 17(7):901–909. doi:10.1007/s10552-006-0023-9

    Article  PubMed  Google Scholar 

  15. Kuriyama S, Tsubono Y, Hozawa A, Shimazu T, Suzuki Y, Koizumi Y, Suzuki Y, Ohmori K, Nishino Y, Tsuji I (2005) Obesity and risk of cancer in Japan. Int J Cancer 113(1):148–157. doi:10.1002/ijc.20529

    Article  CAS  PubMed  Google Scholar 

  16. Tulinius H, Sigfusson N, Sigvaldason H, Bjarnadottir K, Tryggvadottir L (1997) Risk factors for malignant diseases: a cohort study on a population of 22,946 Icelanders. Cancer Epidemiol Biomark Prev 6(11):863–873

    CAS  Google Scholar 

  17. Renehan AG, Tyson M, Egger M, Heller RF, Zwahlen M (2008) Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Lancet 371(9612):569–578. doi:10.1016/S0140-6736(08)60269-X

    Article  PubMed  Google Scholar 

  18. International WCRF (2015) Continuous update project. Diet, nutrition, physical activity and kidney cancer

    Google Scholar 

  19. Renehan AG, Soerjomataram I, Tyson M, Egger M, Zwahlen M, Coebergh JW, Buchan I (2010) Incident cancer burden attributable to excess body mass index in 30 European countries. Int J Cancer 126(3):692–702. doi:10.1002/ijc.24803

    Article  CAS  PubMed  Google Scholar 

  20. Nicodemus KK, Sweeney C, Folsom AR (2004) Evaluation of dietary, medical and lifestyle risk factors for incident kidney cancer in postmenopausal women. Int J Cancer 108(1):115–121. doi:10.1002/ijc.11532

    Article  CAS  PubMed  Google Scholar 

  21. Pischon T, Lahmann PH, Boeing H, Tjonneland A, Halkjaer J, Overvad K, Klipstein-Grobusch K, Linseisen J, Becker N, Trichopoulou A, Benetou V, Trichopoulos D, Sieri S, Palli D, Tumino R, Vineis P, Panico S, Monninkhof E, Peeters PH, Bueno-de-Mesquita HB, Buchner FL, Ljungberg B, Hallmans G, Berglund G, Gonzalez CA, Dorronsoro M, Gurrea AB, Navarro C, Martinez C, Quiros JR, Roddam A, Allen N, Bingham S, Khaw KT, Kaaks R, Norat T, Slimani N, Riboli E (2005) Body size and risk of renal cell carcinoma in the European prospective investigation into cancer and nutrition (EPIC). Int J Cancer

    Google Scholar 

  22. Adams KF, Leitzmann MF, Albanes D, Kipnis V, Moore SC, Schatzkin A, Chow WH (2008) Body size and renal cell cancer incidence in a large US cohort study. Am J Epidemiol. doi:10.1093/aje/kwn122 (kwn122 [pii])

  23. Luo J, Margolis KL, Adami HO, Lopez AM, Lessin L, Ye W, Women’s Health Initiative I (2007) Body size, weight cycling, and risk of renal cell carcinoma among postmenopausal women: the women’s health initiative (United States). Am J Epidemiol 166(7):752–759. doi:10.1093/aje/kwm137

    Article  PubMed  Google Scholar 

  24. Hughes LA, Schouten LJ, Goldbohm RA, van den Brandt PA, Weijenberg MP (2009) Self-reported clothing size as a proxy measure for body size. Epidemiology 20(5):673–676. doi:10.1097/EDE.0b013e3181a66eb5

    Article  PubMed  Google Scholar 

  25. Norat T, Aune D, Chan D, Romaguera D (2014) Fruits and vegetables: updating the epidemiologic evidence for the WCRF/AICR lifestyle recommendations for cancer prevention. Cancer Treat Res 159:35–50. doi:10.1007/978-3-642-38007-5_3

    Article  CAS  PubMed  Google Scholar 

  26. Lindblad P, Wolk A, Bergstrom R, Persson I, Adami HO (1994) The role of obesity and weight fluctuations in the etiology of renal cell cancer: a population-based case-control study. Cancer Epidemiol Biomark Prev 3(8):631–639

    CAS  Google Scholar 

  27. Mellemgaard A, Lindblad P, Schlehofer B, Bergstrom R, Mandel JS, McCredie M, McLaughlin JK, Niwa S, Odaka N, Pommer W et al (1995) International renal-cell cancer study. III. Role of weight, height, physical activity, and use of amphetamines. Int J Cancer 60(3):350–354

    Article  CAS  PubMed  Google Scholar 

  28. Linehan WM, Ricketts CJ (2013) The metabolic basis of kidney cancer. Semin Cancer Biol 23(1):46–55. doi:10.1016/j.semcancer.2012.06.002

    Article  CAS  PubMed  Google Scholar 

  29. Solarek W, Czarnecka AM, Escudier B, Bielecka ZF, Lian F, Szczylik C (2015) Insulin and IGFs in renal cancer risk and progression. Endocr Relat Cancer 22(5):R253–R264. doi:10.1530/ERC-15-0135

    Article  CAS  PubMed  Google Scholar 

  30. Datta K, Nambudripad R, Pal S, Zhou M, Cohen HT, Mukhopadhyay D (2000) Inhibition of insulin-like growth factor-I-mediated cell signaling by the von Hippel-Lindau gene product in renal cancer. J Biol Chem 275(27):20700–20706. doi:10.1074/jbc.M909970199

    Article  CAS  PubMed  Google Scholar 

  31. Spyridopoulos TN, Petridou ET, Skalkidou A, Dessypris N, Chrousos GP, Mantzoros CS, Obesity, Cancer Oncology G (2007) Low adiponectin levels are associated with renal cell carcinoma: a case-control study. Int J Cancer 120(7):1573–1578. doi:10.1002/ijc.22526

  32. Liao LM, Schwartz K, Pollak M, Graubard BI, Li Z, Ruterbusch J, Rothman N, Davis F, Wacholder S, Colt J, Chow WH, Purdue MP (2013) Serum leptin and adiponectin levels and risk of renal cell carcinoma. Obesity (Silver Spring) 21(7):1478–1485. doi:10.1002/oby.20138

    Article  CAS  Google Scholar 

  33. Liao LM, Weinstein SJ, Pollak M, Li Z, Virtamo J, Albanes D, Chow WH, Purdue MP (2013) Prediagnostic circulating adipokine concentrations and risk of renal cell carcinoma in male smokers. Carcinogenesis 34(1):109–112. doi:10.1093/carcin/bgs322

    Article  PubMed  Google Scholar 

  34. Purdue MP, Moore LE, Merino MJ, Boffetta P, Colt JS, Schwartz KL, Bencko V, Davis FG, Graubard BI, Janout V, Ruterbusch JJ, Beebe-Dimmer J, Cote ML, Shuch B, Mates D, Hofmann JN, Foretova L, Rothman N, Szeszenia-Dabrowska N, Matveev V, Wacholder S, Zaridze D, Linehan WM, Brennan P, Chow WH (2013) An investigation of risk factors for renal cell carcinoma by histologic subtype in two case-control studies. Int J Cancer 132(11):2640–2647. doi:10.1002/ijc.27934

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  35. Dal Maso L, Zucchetto A, Tavani A, Montella M, Ramazzotti V, Talamini R, Canzonieri V, Garbeglio A, Negri E, Tonini A, La Vecchia C, Franceschi S (2007) Renal cell cancer and body size at different ages: an Italian multicenter case-control study. Am J Epidemiol 166(5):582–591. doi:10.1093/aje/kwm108

    Article  PubMed  Google Scholar 

  36. Park YH, Lee JK, Kim KM, Kook HR, Lee H, Kim KB, Lee S, Byun SS, Lee SE (2014) Visceral obesity in predicting oncologic outcomes of localized renal cell carcinoma. J Urol 192(4):1043–1049. doi:10.1016/j.juro.2014.03.107

    Article  PubMed  Google Scholar 

  37. Kaneko G, Miyajima A, Yuge K, Yazawa S, Mizuno R, Kikuchi E, Jinzaki M, Oya M (2015) Visceral obesity is associated with better recurrence-free survival after curative surgery for Japanese patients with localized clear cell renal cell carcinoma. Jpn J Clin Oncol 45(2):210–216. doi:10.1093/jjco/hyu193

    Article  PubMed  Google Scholar 

  38. Edge SB, Compton CC (2010) The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM. Ann Surg Oncol 17(6):1471–1474. doi:10.1245/s10434-010-0985-4

    Article  PubMed  Google Scholar 

  39. Institute NC SEER cancer statistics factsheets: kidney and renal pelvis cancer. http://seer.cancer.gov/statfacts/html/kidrp.html

  40. Novara G, Martignoni G, Artibani W, Ficarra V (2007) Grading systems in renal cell carcinoma. J Urol 177(2):430–436. doi:10.1016/j.juro.2006.09.034

    Article  PubMed  Google Scholar 

  41. Delahunt B, Egevad L, Samaratunga H, Martignoni G, Nacey JN, Srigley JR (2015) Gleason and Fuhrman no longer make the grade. Histopathology. doi:10.1111/his.12803

    PubMed Central  Google Scholar 

  42. Parker AS, Lohse CM, Cheville JC, Thiel DD, Leibovich BC, Blute ML (2006) Greater body mass index is associated with better pathologic features and improved outcome among patients treated surgically for clear cell renal cell carcinoma. Urology 68(4):741–746. doi:10.1016/j.urology.2006.05.024

    Article  PubMed  Google Scholar 

  43. Awakura Y, Nakamura E, Ito N, Yamasaki T, Kamba T, Kamoto T, Ogawa O (2007) Influence of body mass index on prognosis of Japanese patients with renal cell carcinoma. Urology 70(1):50–54. doi:10.1016/j.urology.2007.03.034

    Article  PubMed  Google Scholar 

  44. Schrader AJ, Rustemeier J, Rustemeier JC, Timmesfeld N, Varga Z, Hegele A, Olbert PJ, Hofmann R (2009) Overweight is associated with improved cancer-specific survival in patients with organ-confined renal cell carcinoma. J Cancer Res Clin Oncol 135(12):1693–1699. doi:10.1007/s00432-009-0616-2

    Article  PubMed  Google Scholar 

  45. Jeon HG, Jeong IG, Lee JH, Lee CJ, Kwak C, Kim HH, Lee SE, Lee E (2010) Prognostic value of body mass index in Korean patients with renal cell carcinoma. J Urol 183(2):448–454. doi:10.1016/j.juro.2009.10.004

    Article  PubMed  Google Scholar 

  46. Naya Y, Zenbutsu S, Araki K, Nakamura K, Kobayashi M, Kamijima S, Imamoto T, Nihei N, Suzuki H, Ichikawa T, Igarashi T (2010) Influence of visceral obesity on oncologic outcome in patients with renal cell carcinoma. Urol Int 85(1):30–36. doi:10.1159/000318988

    Article  PubMed  Google Scholar 

  47. Waalkes S, Merseburger AS, Kramer MW, Herrmann TR, Wegener G, Rustemeier J, Hofmann R, Schrader M, Kuczyk MA, Schrader AJ (2010) Obesity is associated with improved survival in patients with organ-confined clear-cell kidney cancer. Cancer Causes Control 21(11):1905–1910. doi:10.1007/s10552-010-9618-2

    Article  PubMed  Google Scholar 

  48. Komura K, Inamoto T, Black PC, Koyama K, Katsuoka Y, Watsuji T, Azuma H (2011) Prognostic significance of body mass index in Asian patients with localized renal cell carcinoma. Nutr Cancer 63(6):908–915. doi:10.1080/01635581.2011.594207

    Article  PubMed  Google Scholar 

  49. Choi Y, Park B, Jeong BC, Seo SI, Jeon SS, Choi HY, Adami HO, Lee JE, Lee HM (2013) Body mass index and survival in patients with renal cell carcinoma: a clinical-based cohort and meta-analysis. Int J Cancer 132(3):625–634. doi:10.1002/ijc.27639

    Article  CAS  PubMed  Google Scholar 

  50. Hakimi AA, Furberg H, Zabor EC, Jacobsen A, Schultz N, Ciriello G, Mikklineni N, Fiegoli B, Kim PH, Voss MH, Shen H, Laird PW, Sander C, Reuter VE, Motzer RJ, Hsieh JJ, Russo P (2013) An epidemiologic and genomic investigation into the obesity paradox in renal cell carcinoma. J Natl Cancer Inst 105(24):1862–1870. doi:10.1093/jnci/djt310

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  51. Ohno Y, Nakashima J, Nakagami Y, Satake N, Gondo T, Ohori M, Hatano T, Tachibana M (2013) Sex and the clinical value of body mass index in patients with clear cell renal cell carcinoma. Br J Cancer 109(7):1899–1903. doi:10.1038/bjc.2013.512

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  52. Lee HW, Jeong BC, Seo SI, Jeon SS, Lee HM, Choi HY, Jeon HG (2015) Prognostic significance of visceral obesity in patients with advanced renal cell carcinoma undergoing nephrectomy. Int J Urol 22(5):455–461. doi:10.1111/iju.12716

    Article  PubMed  Google Scholar 

  53. Mano R, Hakimi AA, Zabor EC, Bury MA, Donati OF, Karlo CA, Bazzi WM, Furberg H, Russo P (2014) Association between visceral and subcutaneous adiposity and clinicopathological outcomes in non-metastatic clear cell renal cell carcinoma. Can Urol Assoc J 8(9–10):E675–E680. doi:10.5489/cuaj.1979

    Article  PubMed  PubMed Central  Google Scholar 

  54. Lee WK, Hong SK, Lee S, Kwak C, Oh JJ, Jeong CW, Kim YJ, Kang SH, Hong SH, Byun SS (2015) Prognostic value of body mass index according to histologic subtype in nonmetastatic renal cell carcinoma: a large cohort analysis. Clin Genitourin Cancer 13(5):461–468. doi:10.1016/j.clgc.2015.04.012

    Article  PubMed  Google Scholar 

  55. Lajous M, Bijon A, Fagherazzi G, Boutron-Ruault MC, Balkau B, Clavel-Chapelon F, Hernan MA (2014) Body mass index, diabetes, and mortality in French women: explaining away a “paradox”. Epidemiology 25(1):10–14. doi:10.1097/EDE.0000000000000031

    Article  PubMed  PubMed Central  Google Scholar 

  56. Lajous M, Banack HR, Kaufman JS, Hernan MA (2015) Should patients with chronic disease be told to gain weight? The obesity paradox and selection bias. Am J Med 128(4):334–336. doi:10.1016/j.amjmed.2014.10.043

    Article  PubMed  Google Scholar 

  57. Banack HR, Kaufman JS (2014) The obesity paradox: understanding the effect of obesity on mortality among individuals with cardiovascular disease. Prev Med 62:96–102. doi:10.1016/j.ypmed.2014.02.003

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA

    Kathryn M. Wilson

  2. Channing Division of Network Medicine, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, USA

    Kathryn M. Wilson & Eunyoung Cho

  3. Department of Dermatology, Warren Alpert Medical School, Brown University, Providence, RI, USA

    Eunyoung Cho

  4. Department of Epidemiology, School of Public Health, Brown University, Providence, RI, USA

    Eunyoung Cho

Authors
  1. Kathryn M. Wilson
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Eunyoung Cho
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Eunyoung Cho .

Editor information

Editors and Affiliations

  1. Molecular Epidemiology Research Group, Max Delbrück Center for Molecular Medicine in the Helmholtz Association (MDC), Robert-Rössle-Straße , Berlin, Germany

    Tobias Pischon

  2. Molecular Epidemiology Research Group, Max Delbrück Center for Molecular Medicine in the Helmholtz Association (MDC), Robert-Rössle-Straße, Berlin, Germany

    Katharina Nimptsch

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Wilson, K.M., Cho, E. (2016). Obesity and Kidney Cancer. In: Pischon, T., Nimptsch, K. (eds) Obesity and Cancer. Recent Results in Cancer Research, vol 208. Springer, Cham. https://doi.org/10.1007/978-3-319-42542-9_5

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-42542-9_5

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-42540-5

  • Online ISBN: 978-3-319-42542-9

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation